Business

In a significant development, the Federal Trade Commission (FTC) has initiated legal proceedings against PepsiCo, claiming the company has engaged in unlawful price discrimination practices. At the center of this controversy is an unnamed major retailer, which sources suggest is Walmart, that allegedly received preferential pricing and promotional support that were not extended to PepsiCo’s
0 Comments
In the landscape of banking, the term “excess capital” typically elicits interest from investors and analysts alike. JPMorgan Chase finds itself with a notable surplus, roughly estimated at $35 billion. This accumulation, characterized by its CFO Jeremy Barnum as a “high-class problem,” arises from the need to comply with regulatory requirements while amassing substantial profits.
0 Comments
Eli Lilly & Co. recently made headlines by adjusting its revenue guidance for the upcoming year, a decision that reflects broader challenges within the pharmaceutical industry, particularly in the competitive arena of weight loss and diabetes medications. Originally forecasting a revenue range of $45.4 billion to $46 billion, the company has now set its sights
0 Comments
The holiday shopping season, traditionally a time when retailers see a significant uptick in sales, has produced mixed results for major brands this year. Despite some companies reporting better-than-expected earnings, investment sentiment has taken a hit, evidenced by plummeting stock prices. This disparity between growing sales forecasts and declining share values raises important questions about
0 Comments